The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.

Bilici, AhmetGöktaş Aydın, SabinÇakır, AslıÖlmez, Ömer FatihErol, Vedat Buğra2024-03-132024-03-132023Bilici, A., Göktaş Aydın, S., Çakır, A., Ölmez, Ö. F. ve Erol, V. B. (2023). The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June, 2023.0732-183X1527-7755https://hdl.handle.net/20.500.12511/12362[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessBreast Cancer PatientsTumor-Infiltrating Lymphocyte (TIL)ChemotherapyThe relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.Conference Object4116Q1001053772000670